home.aspx
 
.

Webinars

UTILITY OF GENERATING <665> DATA: DRUG MANUFACTURE’S PERSPECTIVE: WILL USP PERMIT SUCH FORMAT?
UTILITY OF GENERATING <665> DATA: DRUG MANUFACTURE’S PERSPECTIVE: WILL USP PERMIT SUCH FORMAT?
January 21-21, 2020
Integrating Data in Drug Manufacturing, How Data and the Internet of Things Will Impact and Optimize Process. Integrating data from the drug development phase through drug manufacturing presents an additional set of challenges. As with drug development, the infrastructure needed to manage the data i...

Utility of Generating Data: Drug Manufacture Perspective
UTILITY OF GENERATING DATA: DRUG MANUFACTURE PERSPECTIVE
January 21-21, 2020
Ken Wong is a Deputy Director of Process Technology Platform at Sanofi Pasteur. Serving as the Swiftwater site extractables and leachables (E&L) SME but also provide E&L supports to all global sites. His 19-year in biopharma professional career has ranged from R&D to development and comm...

Impacts the Health Care System Has on Your Employee Population
IMPACTS THE HEALTH CARE SYSTEM HAS ON YOUR EMPLOYEE POPULATION
January 21-21, 2020
In this webinar, our population health expert will discuss common and uncommon characteristics that medical facilities, pharmacies and other players use to generate revenue from your benefit plan.

Tufts CSDD Study Assessing the Financial Benefits of Translational Pharmaceutics: A Platform for Accelerating Product Development
TUFTS CSDD STUDY ASSESSING THE FINANCIAL BENEFITS OF TRANSLATIONAL PHARMACEUTICS: A PLATFORM FOR ACCELERATING PRODUCT DEVELOPMENT
January 22-22, 2020
The drug development process has been demonstrated to be highly costly, lengthy, and risky with significant rates of molecule attrition. Despite long-standing efforts by drug developers to operate more efficiently, traditional drug development programs have become costlier on average. To inform drug...

Tufts CSDD Study Assessing the Financial Benefits of Translational Pharmaceutics®: A Platform for Accelerating Product Development
TUFTS CSDD STUDY ASSESSING THE FINANCIAL BENEFITS OF TRANSLATIONAL PHARMACEUTICS®: A PLATFORM FOR ACCELERATING PRODUCT DEVELOPMENT
January 22-22, 2020
The drug development process has been demonstrated to be extremely costly, lengthy, and risky with significant rates of molecule attrition. Despite long-standing efforts by drug developers to operate more efficiently, traditional drug development programs have become costlier on average. To inform d...

Integrated Drug discovery at Jubilant Biosys – our experiences with Biotech partners on accelerating the drug discovery process
INTEGRATED DRUG DISCOVERY AT JUBILANT BIOSYS – OUR EXPERIENCES WITH BIOTECH PARTNERS ON ACCELERATING THE DRUG DISCOVERY PROCESS
January 22-22, 2020
Drug discovery is a complex process that requires cross functional scientific expertise and knowledge in disease biology. Jubilant’s understanding of disease biology is constantly evolving with every emerging literature and new technologies are enabling investigations that were deemed unviable...

Supply Chain Security – A Comprehensive Examination of the Latest Technical Challenges from Procurement of Raw Materials to Distribution of Drug Products
SUPPLY CHAIN SECURITY – A COMPREHENSIVE EXAMINATION OF THE LATEST TECHNICAL CHALLENGES FROM PROCUREMENT OF RAW MATERIALS TO DISTRIBUTION OF DRUG PRODUCTS
January 22-22, 2020
This exclusive live training webinar is designed to provide both technical and regulatory requirements as you design and implement your supply chain from procurement of raw materials to the distribution of your products to the customers. Things are changing in the market place. Products are becoming...

A Tufts Study of 30 Pharma Companies
A TUFTS STUDY OF 30 PHARMA COMPANIES
January 23-23, 2020
Real world evidence (RWE) is making its way into your world. The Tufts Center for the Study of Drug Development (CSDD) investigated how the industry is using real world data (RWD) and RWE. The study of 30 biopharmaceutical companies includes current and planned used of RWD, operational issues and re...

Establishing Safety and Efficacy in the OTC Environment 
ESTABLISHING SAFETY AND EFFICACY IN THE OTC ENVIRONMENT 
January 27-27, 2020
The Rx-to-OTC Switch represents an important opportunity to extend product lifecycle and create a permanent annuity which helps consumers manage their own care and reduce burden on the healthcare system.  There exists a legacy of essential OTC products which underwent this challenging process a...

Cartridge Based Drug Delivery…Evolving Technologies Designed With the Patient in Mind.
CARTRIDGE BASED DRUG DELIVERY…EVOLVING TECHNOLOGIES DESIGNED WITH THE PATIENT IN MIND.
January 28-28, 2020
As the industry continues to see significant growth for drug products developed using cartridge-based drug delivery systems, there is a trend for pharmaceutical companies to evaluate more complex drug molecules, such as biologics, that require higher injection volume or viscosity.  These biolog...

Data Analytics in biopharma manufacturing
DATA ANALYTICS IN BIOPHARMA MANUFACTURING
January 28-28, 2020
Find out how new operating systems for the industrial Internet of Things can enable flexible, open connectivity solutions for physical infrastructure as well as enterprise resource planning, manufacturing execution systems, supervisory control and data acquisition, and more.

2020 Annual Pharmaceutical Impurities Training Program
2020 ANNUAL PHARMACEUTICAL IMPURITIES TRAINING PROGRAM
February 05-05, 2020
As an important part of Good Manufacturing Practices (GMPs), monitoring impurities has been placed on the critical path of the development of pharmaceutical products. The objective of this live 4-part series is to thoroughly examine key best practices and regulations in this area. This live training...

Applying behavioural interventions in chronic diseases
APPLYING BEHAVIOURAL INTERVENTIONS IN CHRONIC DISEASES
February 06-06, 2020
Chronic diseases are the leading cause of death and disability worldwide and have a staggering impact on patients’ lives and the provision of healthcare around the world. Tackling conditions such as diabetes, heart disease and stroke is of vital importance if patient outcomes are to be improve...

Free MSL webinar for Scientist, Pharmacist & Medical Doctors
FREE MSL WEBINAR FOR SCIENTIST, PHARMACIST & MEDICAL DOCTORS
February 08-08, 2020
If you are unsure if you can make it on the day, just sign up and we will send you the link to the recording of the webinar. Click "show in my timezone" to select your timezone and then click on the little triangle on the right to choose out of several different dates and time zones!

HIGH-RESOLUTION CHARACTERIZATION OF STRUCTURE, INTERACTION, AND MISCIBILITY OF DRUG PRODUCTS
HIGH-RESOLUTION CHARACTERIZATION OF STRUCTURE, INTERACTION, AND MISCIBILITY OF DRUG PRODUCTS
February 11-11, 2020
The local interactions between a drug and its surrounding environment is critical in both small and large molecule formulations. For small molecules, the drug-polymer interaction is needed to ensure that the drug does not crystallize in an amorphous solid dispersion. For proteins, phase separation i...

Industry Trends in Pre-approval Access to Medicines
INDUSTRY TRENDS IN PRE-APPROVAL ACCESS TO MEDICINES
February 20-20, 2020
Expanded access to medicines (pre-approval access, early access, compassionate use, named patient supply) is becoming more and more a part of the standard development and launch process of bringing a pharmaceutical product to market. The focus of pipelines on rare diseases and oncology, combined wit...

2020 Pharmaceutical Cleaning Validation Regulatory Compliance Training Program
2020 PHARMACEUTICAL CLEANING VALIDATION REGULATORY COMPLIANCE TRAINING PROGRAM
February 25-25, 2020
This intensive 8-part live training program on the topic of Cleaning Validation will consist of 8 live training sessions of 2 hours each. It will include over 20 hours of live presentation and live Q&A delivered twice a month over the course of 4 months.

2020 Annual Pharmaceutical Cleaning Validation Training Program
2020 ANNUAL PHARMACEUTICAL CLEANING VALIDATION TRAINING PROGRAM
February 25-25, 2020
Pharmaceutical manufacturers must validate their cleaning processes to ensure compliance with the latest regulatory requirements. Effective and consistent cleaning procedures must be in place and thoroughly validated to avoid cross-contamination in manufacturing and cleaning equipment. In recent yea...

FDA & International Stability Requirements in the Drug Development Process
FDA & INTERNATIONAL STABILITY REQUIREMENTS IN THE DRUG DEVELOPMENT PROCESS
March 11-11, 2020
This live and interactive session will focus on key issues to keep the stability program in compliance. It will review global stability guidelines Q1A(R2), discuss climatic zones and stability requirements of non-ICH countries.

FDA & International Stability Requirements in the Drug Development Process including WHO, ASEAN and ICH Q1AR2
FDA & INTERNATIONAL STABILITY REQUIREMENTS IN THE DRUG DEVELOPMENT PROCESS INCLUDING WHO, ASEAN AND ICH Q1AR2
March 11-11, 2020
Stability is a Critical Quality Attribute, and stability program plays an important role in the Drug Development Process. It is necessary to determine the storage condition and expiry of pharmaceutical products. Several international guidelines have been issued for stability program and companies mu...

Elemental Impurities Compliance for the Pharmaceutical Industry
ELEMENTAL IMPURITIES COMPLIANCE FOR THE PHARMACEUTICAL INDUSTRY
March 18-18, 2020
The objective of this live training webinar is to provide an understanding of the new USP standards and the ICH Q3D guideline, including new initiatives to correct an error with the cadmium inhalation-route value and to determine elements and permissible daily exposure limits for transdermal and cut...

PHARMACEUTICAL-BIOTECH INDUSTRY: 2020
PHARMACEUTICAL-BIOTECH INDUSTRY: 2020'S BIGGEST TRENDS
April 08-08, 2020
Join us as we delve into the key market trends impacting spending, and a look at the sectors expected to lead capex investment in 2020.

Pharmaceutical Cleaning Validation
PHARMACEUTICAL CLEANING VALIDATION
May 21-21, 2020
For this live training webinar, regulatory issues related to validation maintenance will be discussed. Validation maintenance procedures covered include routine monitoring, preventive maintenance, change control, deviation management, retraining and revalidation. Under revalidation, both a repeat of...

Opioid Crisis 2020
OPIOID CRISIS 2020
November 03-03, 2020
The Opioid epidemic has been called the worst drug crisis in American history.  Join us as we discuss and exchange thoughts on the rise, spread, and control of Opioids.

SPOTLIGHT

Over the past few years, neuroscientists have been able to grow ever larger and more complex spheroid cultures and organoids that replicate the structure and functionality of brain tissue. While these...